Abecma genetically modified autologous T cells for infusion Images
Generic Name: idecabtagene vicleucel
This medication has been identified as Abecma genetically modified autologous T cells for infusion and is used for Multiple Myeloma. It belongs to the drug class miscellaneous antineoplastics and is not a controlled substance.
Images of medication
Abecma
- Generic Name
- idecabtagene vicleucel
- Strength
- genetically modified autologous T cells for infusion
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Celgene Corporation
- National Drug Code (NDC)
- 59572-0515
See also:
More about Abecma (idecabtagene vicleucel)
- Check interactions
- Compare alternatives
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.